A detailed history of Jackson Creek Investment Advisors LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 76,540 shares of TGTX stock, worth $2.21 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
76,540
Previous 59,356 28.95%
Holding current value
$2.21 Million
Previous $1.06 Million 69.51%
% of portfolio
0.53%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$17.21 - $25.28 $295,736 - $434,411
17,184 Added 28.95%
76,540 $1.79 Million
Q2 2024

Aug 01, 2024

SELL
$13.32 - $19.19 $1,212 - $1,746
-91 Reduced 0.15%
59,356 $1.06 Million
Q1 2024

May 09, 2024

BUY
$13.02 - $21.3 $773,999 - $1.27 Million
59,447 New
59,447 $904,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.2B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.